Covestor
ORKA icon

Covestor’s Oruka Therapeutics ORKA Stock Holding History

Covestor’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1K Sell
7
-4
-36% -$377 ﹤0.01% 2234
2026
Q2 		$1K Buy
11
+7
+175% +$466 ﹤0.01% 2413
2026
Q1 		$0 Buy
+4
New +$139 ﹤0.01% 2868

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Covestor's ORKA Position: Q3 2026 in Review

Covestor reduced its Oruka Therapeutics (ORKA) stake by 36% in Q3 2026, selling an estimated $377 and leaving 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

Covestor first reported a position in ORKA in Q1 2026 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Covestor held 7 shares of Oruka Therapeutics worth $1K as of Q3 2026.
  • Covestor sold 4 Oruka Therapeutics shares in Q3 2026, an estimated $377.
  • Oruka Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2234 holding.
  • Covestor first reported a position in Oruka Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.